RE: Annual Report is ....Net Loss Down 26.3%
Another interesting piece of the puzzle placed........Yup!!
Dr. Cruz and the boys have decreased Net Loss by over 26% for the year. Good Job!!
Financial Review
For the year ended June 30, 2007, Transition recorded a net loss of $16,961,790 ($0.87 per common share) compared to a net loss of $23,018,090 ($1.53 per common share) for the fiscal year ended June 30, 2006. {Thats a 26.3% Decrease in Net Loss}
Research and development expenses excluding amortization of intangibles decreased to $9,839,170 for the fiscal year ended June 30, 2007 from $11,060,455 for the same period in 2006. The decrease of $1,221,285 or 11% was primarily the result of a reduction in Research and Development expense resulting from Expense Reimbursements from Elan, Novo Nordisk and the JDRF,
Good Job I say .......Cheers!!